More than half of melanoma patients whose cancer initially responds to immunotherapy will eventually see their disease return ...

Subtle signs of skin cancer you shouldn't ignore When the weather gets warmer and daylight hours longer, people are more ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...

Because aircraft personnel are routinely exposed to galactic cosmic radiation and ultraviolet radiation, they face an elevated risk for certain cancers.

Pembrolizumab plus EVX-01, a personalized peptide-based neoantigen cancer vaccine, demonstrated the “ability to induce potent and sustained T-cell responses” among patients with previously untreated, ...

The latest update is out from Scancell Holdings ( (GB:SCLP) ).

Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.

Please provide your email address to receive an email when new articles are posted on . Adults with only one tattoo session had slightly elevated melanoma risk compared with tattoo-free individuals.

NANJING, China, Sept. 12, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the first patient has been successfully dosed in ...

LOS ANGELES (KABC) -- It's a pesky virus that affects two-thirds of the world population, but now USC researchers are turning the herpes simplex virus into an effective cancer fighter. One skin cancer ...

The FDA’s recent rebuff of Replimune’s melanoma candidate has rippled across the industry, prompting one biotech to shutter a clinical trial evaluating a similar drug. Krystal Biotech has discontinued ...

Background: Anorectal malignant melanoma (ARMM) is an exceedingly rare and highly aggressive malignancy characterized by low prevalence, high misdiagnosis rates, and frequent recurrence/metastasis.